Thermo Fisher Scientific  logo

Thermo Fisher Scientific TMO

$ 555.5 -0.43%

Quarterly report 2024-Q3
added 11-01-2024

report update icon

Country

usaUSA

IPO year

-

Industry

Diagnostics research

Stock Exchange

NYSESPB

CEO

Mr. Marc Casper

Employees in the company

75 000

Shares

386 M

Market Cap[1]

$ 214 B

EBITDA (LTM)

$ 8.2 B

P/E (LTM)

34.4

P/S (LTM)

5.12

EPS (LTM)

16.22

Thermo Fisher Scientific is a globally leading company in the life science industry, focusing on the development and manufacturing of products and services for research, diagnostics, and drug production. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Thermo Fisher Scientific offers a wide range of products, including laboratory equipment, reagents, consumables, software, and services. The company serves customers in the pharmaceutical and biotech, diagnostics, academic research, and government sectors.

The mission of Thermo Fisher Scientific is to help its customers make the world healthier, cleaner, and safer. The company is also committed to sustainability and aims to reduce its greenhouse gas emissions by 50% by 2030.

Thermo Fisher Scientific is known for its innovation and has received numerous awards for its products and technologies. The company has also made several acquisitions to expand its product offerings and strengthen its presence in different regions.

Overall, is a leading company in the life science industry that is committed to innovation, sustainability, and customer satisfaction. Its products and services have a positive impact on the health and well-being of people around the world.

Other stocks of industry "Diagnostics research"

Issuer Price % 24h Market Cap Exchange Country
Accelerate Diagnostics Accelerate Diagnostics
AXDX
$ 1.85 -4.39 % $ 152 M Nasdaq Global Select Market usaUSA
Fluidigm Corporation Fluidigm Corporation
FLDM
$ 3.75 1.08 % $ 308 M Nasdaq Global Select Market usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
$ 2.99 - $ 399 M NYSE chinaChina
Genetron Holdings Limited Genetron Holdings Limited
GTH
$ 4.03 0.12 % $ 80.1 M Nasdaq Global Market chinaChina
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
$ 21.99 - $ 562 M Nasdaq Global Select Market britainBritain
Enzo Biochem Enzo Biochem
ENZ
$ 1.13 -0.13 % $ 57.5 K NYSE usaUSA
Illumina Illumina
ILMN
$ 153.6 2.56 % $ 24.3 B Nasdaq Global Select Market,SPB usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 210.75 0.76 % $ 38.7 B NYSE,SPB usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
$ 0.46 0.22 % $ 16.8 M Nasdaq Capital Market usaUSA
Bioventus Bioventus
BVS
$ 13.81 1.69 % $ 865 M Nasdaq Global Select Market usaUSA
Meridian Bioscience Meridian Bioscience
VIVO
$ 33.97 - $ 1.49 B Nasdaq Global Select Market usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
$ 0.48 -20.0 % $ 1.06 M Nasdaq Capital Market usaUSA
Organovo Holdings Organovo Holdings
ONVO
$ 0.44 -6.45 % $ 4.02 M Nasdaq Capital Market usaUSA
OPKO Health OPKO Health
OPK
$ 1.48 -2.01 % $ 1.11 B Nasdaq Global Select Market usaUSA
Quotient Limited Quotient Limited
QTNT
$ 0.32 -11.32 % $ 1.1 M Nasdaq Global Select Market schweizSchweiz
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 2.5 2.46 % $ 634 M Nasdaq Global Select Market,SPB usaUSA
Koninklijke Philips N.V. Koninklijke Philips N.V.
PHG
$ 27.11 2.34 % $ 20 B NYSE niderlandNiderland
Psychemedics Corporation Psychemedics Corporation
PMD
$ 2.32 - $ 13.3 M Nasdaq Global Select Market usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
$ 43.67 1.37 % $ 9.96 B NYSE niderlandNiderland
Personalis Personalis
PSNL
$ 2.17 -14.57 % $ 102 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.